Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by kingdaron Mar 04, 2010 3:30pm
580 Views
Post# 16844372

Spoke to Allan Moore today

Spoke to Allan Moore todayCalled SSS today and decided to try allans extenstion and got a recording to call his cell. Called and got his message manager. Left a message for him to call back, not expecting him to return my call. To my suprise he did call me and had a chat on the present situation. He told me not to worry as this is all due to the pp. He said only good things to come. I did ask the question-- Does this treatment work?  He said it is the most consistent result he's ever seen . The results on animals and the phase1 on humans were all consistant. And he expects the phase 2 results the same. The results from India may be out sooner as they are discussing it now. He said he has not seen the data yet as it is a blind test. Very nice man. I just bought more. 
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse